Insider trades
David Hung, Director of NovoCure NVCR, has filed 3 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $46.4K. The latest trade was on 06/03.
David Hung
Director
- Company
- NovoCure NVCR
- First filing
- 23/03/02
- Trades
- 17 trades
- Buys / sales
- 3 / 2
- 12-month net buying
- −$46.4K
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NovoCureNVCR | Open-market sale | 06/02 | 06/03 | 2,945 sh | $15.77 | $46,442.65 | −12.6% |
Nuvation BioNUVB | Open-market buy | 25/06/16 | 25/06/18 | 500,000 sh | $1.79 | $895,000 | +0.9% |
NovoCureNVCR | Open-market sale | 25/06/03 | 25/06/04 | 999 sh | $17.30 | $17,282.7 | −7.6% |
NUVB | Open-market buy | 25/04/04–25/04/07 | 25/04/08 | 500,000 sh2 trades | $1.64avg. | $821,000 | +0.9% |
